Evaluation of radiolabeled curcumin-loaded solid lipid nanoparticles usage as an imaging agent in liver-spleen scintigraphy

Materials Science and Engineering C

Volumn 75, Issue , 2017, Pages 663-670

  Ayan, Arif Kursad ^a   Yenilmez, Ayse ^a,b   Eroglu, Hayrettin ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ERZURUM TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Curcumin; Radiolabeling; Scintigraph; Solid lipid nanoparticles; maging

Indexed keywords

COLLOIDS; ELECTRON MICROSCOPY; EMULSIFICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; NANOPARTICLES; NANOTECHNOLOGY; NUCLEAR MEDICINE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION ANALYSIS;

CURCUMIN; FOURIER TRANSFORM INFRA RED (FTIR) SPECTROSCOPY; LASER DIFFRACTIONS; NEW ZEALAND RABBITS; RADIOLABELING; SCINTIGRAPH; SOLID LIPID NANOPARTICLE (SLN); SOLID NANOPARTICLES;

THERMOGRAVIMETRIC ANALYSIS;

CURCUMIN; NANOPARTICLE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; ISOTOPE LABELING; LIVER; MALE; PROCEDURES; RABBITS AND HARES; SCINTISCANNING; SPLEEN;

ANIMALS; CURCUMIN; ISOTOPE LABELING; LIVER; MALE; NANOPARTICLES; RABBITS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SPLEEN; TECHNETIUM;

EID: 85014061519     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2017.02.114     Document Type: Article

References (25)

1. [1] Saha, G.B., Fundamentals of Nuclear Pharmacy. 6rd ed., 2010, Springer Verlag, New York, 83.
2. [2] Margulis, K., Magdassi, S., Lee, H.S., Macosko, C.W., Formation of curcumin nanoparticles by flash nanoprecipitation from emulsions. J. Colloid Interface Sci. 434 (2014), 65–70.
3. [3] Kumar, S.S., Mahesh, A., Mahadevan, S., Mandal, A.B., Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells. Biochim. Biophys. Acta 1840:6 (2014), 1913–1922.
4. [4] Aggarwal, B.B., Harikumar, K.B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41:1 (2009), 40–59.
5. [5] Yadav, D., Kumar, N., Nanonization of curcumin by antisolvent precipitation: process development, characterization, freeze drying and stability performance. Int. J. Pharm. 477:1–2 (2014), 564–577.
6. [6] Anwar, M., Asfer, M., Prajapati, A.P., Mohapatra, S., Akhter, S., Ali, A., Ahmad, F.J., Synthesis and in vitro localization study of curcumin-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system. Int. J. Pharm. 468:1–2 (2014), 158–164.
7. [7] Mohanty, C., Sahoo, S.K., The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31:25 (2010), 6597–6611.
8. [8] Li, B., Konecke, S., Wegiel, L.A., Taylor, L.S., Edgar, K.J., Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices. Carbohydr. Polym. 98:1 (2013), 1108–1116.
9. [9] Gao, Y., Li, Z., Sun, M., Guo, C., Yu, A., Xi, Y., Cui, J., Lou, H., Zhai, G., Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv. 18:2 (2011), 131–142.
10. [10] Yadav, V.R., Prasad, S., Kannappan, R., Ravindran, J., Chaturvedi, M.M., Vaahtera, L., Parkkinen, J., Aggarwal, B.B., Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem. Pharmacol. 80:7 (2010), 1021–1032.
11. [11] Rai, S., Paliwal, R., Gupta, P.N., Khatri, K., Goyal, A.K., Vaidya, B., Vyas, S.P., Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr. Nanosci. 4:1 (2008), 30–44.
12. [12] Andreozzi, E., Seo, J.W., Ferrara, K., Louie, A., Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging. Bioconjug. Chem. 22:4 (2011), 808–818.
13. [13] Kathe, N., Henriksen, B., Chauhan, H., Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev. Ind. Pharm. 40:12 (2014), 1565–1575.
14. [14] Joshy, K.S., Sharma, C.P., Kalarikkal, N., Sandeep, K., Thomas, S., Pothen, L.A., Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells. Mater. Sci. Eng. C Mater. Biol. Appl. 66 (2016), 40–50.
15. [15] Videira, M.A., Botelho, M.F., Santos, A.C., Gouveia, L.F., de Lima, J.J., Almeida, A.J., Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target. 10:8 (2002), 607–613.
16. [16] Kakkar, V., Muppu, S.K., Chopra, K., Kaur, I.P., Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur. J. Pharm. Biopharm. 85:3 Pt A (2013), 339–345.
17. [17] Banerjee, I., De, K., Chattopadhyay, S., Bandyopadhyay, A.K., Misra, M., An easy and effective method for radiolabelling of solid lipid nanoparticles. J. Radioanal. Nucl. Chem. 302:2 (2014), 837–843.
18. [18] Harrington, K.J., Mohammadtaghi, S., Uster, P.S., Glass, D., Peters, A.M., Vile, R.G., Stewart, J.S.W., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 7:2 (2001), 243–254.
19. [19] Kakkar, V., Mishra, A.K., Chuttani, K., Kaur, I.P., Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. Int. J. Pharm. 448:2 (2013), 354–359.
20. [20] Numanoglu, U., Tarımcı, N., Katı lipit nanopartiküllerin özellikleri, farmasötik ve kozmetik alandaki uygulamaları. J. Fac. Pharm. 35 (2006), 211–235.
21. [21] Pople, P.V., Singh, K.K., Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Eur. J. Pharm. Biopharm. 79:1 (2011), 82–94.
22. [22] Manjunath, K., Reddy, J.S., Venkateswarlu, V., Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol. 27:2 (2005), 127–144.
23. [23] Aburahma, M.H., Badr-Eldin, S.M., Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin. Drug Deliv. 11:12 (2014), 1865–1883.
24. [24] Mulik, R.S., Monkkonen, J., Juvonen, R.O., Mahadik, K.R., Paradkar, A.R., Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int. J. Pharm. 398:1–2 (2010), 190–203.
25. [25] Anitha, A., Deepagan, V.G., Divya Rani, V.V., Menon, D., Nair, S.V., Jayakumar, R., Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr. Polym. 84:3 (2011), 1158–1164.